Literature DB >> 12648736

Anhedonia in schizophrenia: a distinct familial subtype?

Franck Schürhoff1, Andrei Szöke, Frank Bellivier, Cristina Turcas, Michelle Villemur, Jean Tignol, Frédéric Rouillon, Marion Leboyer.   

Abstract

Failures to replicate results in psychiatric genetics might be due to our inability to define the heritable phenotype. Instead of relying entirely on classical nosographical approaches, the use of a candidate symptom approach to identify more homogeneous forms of diseases among affected subjects and subclinical traits among first-degree relatives may increase genetic validity. Anhedonia may be a marker for subjects at risk of schizophrenia or schizophrenia spectrum disorders. We compared the familiality of anhedonia characterized by a high level of physical anhedonia (score above 23) in a sample of schizophrenic probands (N=80) and their relatives (N=78), with that in bipolar patients (N=109), their relatives (N=33) and normal controls (N=94). We identified a subform of schizophrenia characterized by highly anhedonic schizophrenic probands with a three-fold higher familial risk of schizophrenia and schizophrenic spectrum disorders. We also found that their first-degree relatives had a high level of anhedonia. An intrafamilial correlation analysis confirmed the familial nature of anhedonia. Our data suggest that anhedonia is a candidate symptom for schizophrenia. Refining phenotype definition by studying subgroups of anhedonic and non-anhedonic probands with relevant candidate genes might be fruitful.

Entities:  

Mesh:

Year:  2003        PMID: 12648736     DOI: 10.1016/s0920-9964(02)00237-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

Review 1.  Anhedonia in schizophrenia.

Authors:  Daniel H Wolf
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

2.  Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients.

Authors:  Vidyulata Kamath; Paul J Moberg; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2011-05-26       Impact factor: 9.306

3.  Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating.

Authors:  Jordy van Enkhuizen; Arpi Minassian; Jared W Young
Journal:  Behav Brain Res       Date:  2013-04-23       Impact factor: 3.332

Review 4.  Anhedonia in schizophrenia: a review of assessment strategies.

Authors:  William P Horan; Ann M Kring; Jack J Blanchard
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

Review 5.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

6.  Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder.

Authors:  Ivy F Tso; Tyler B Grove; Stephan F Taylor
Journal:  Psychiatry Res       Date:  2014-06-25       Impact factor: 3.222

7.  Relative food preference and hedonic judgments in schizophrenia.

Authors:  Bradley S Folley; Sohee Park
Journal:  Psychiatry Res       Date:  2009-11-20       Impact factor: 3.222

8.  Relation between emotional face memory and social anhedonia in schizophrenia.

Authors:  Philippe-Olivier Harvey; Michael Bodnar; Karine Sergerie; Jorge Armony; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2009-03       Impact factor: 6.186

9.  The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients.

Authors:  William P Horan; Steven P Reise; Kenneth L Subotnik; Joseph Ventura; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2008-01-24       Impact factor: 4.939

10.  Anhedonia in schizophrenia and major depression: state or trait?

Authors:  Lorenzo Pelizza; Alberto Ferrari
Journal:  Ann Gen Psychiatry       Date:  2009-10-08       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.